Patent details
301182
Product Name:
roxadustat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301182
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3470397
Status:
Application Pending
Application number:
301182
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/21/1574
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/08/2021
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
24/06/2022
First Marketing Authorization date:
19/08/2021
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/06/2022
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
24/06/2022
Name:
Fibrogen, Inc.
Address:
409 Illinois Street, SAN FRANCISCO, CA 94158, United States of America (US)
Agent
1
Name:
ir. B.Ch. Ledeboer c.s
From:
09/01/2025
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
2
Name:
ir. H.A. Witmans c.s.
From:
24/06/2022
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
09/01/2025
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
26/22
Publication date:
29/06/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
31/01/2023
Outgoing Correspondence
Letter to applicant
1
PDF
/8/5/4/2/0/0800802458/docs/301182_1_493850l173.pdf
27/01/2023
Incoming Correspondence Paper
Incoming Correspondence Paper
1
PDF
/8/5/4/2/0/0800802458/docs/301182_0_incomingcorrespondencepaper20230130083647717.pdf
27/06/2022
Outgoing Correspondence
Confirmation receipt request
1
PDF
/8/5/4/2/0/0800802458/docs/301182_2_489786l174.pdf
24/06/2022
SPC Documents
Accompanying letter SPC
1
PDF
/8/5/4/2/0/0800802458/docs/301182_3_supplprotectioncertificate20220627105732408.pdf
24/06/2022
SPC Documents
Annex SPC
26
PDF
/8/5/4/2/0/0800802458/docs/301182_4_supplprotectioncertificate20220627105732489.pdf
24/06/2022
SPC Documents
Summary of the characteristics of the product
27
PDF
/8/5/4/2/0/0800802458/docs/301182_5_supplprotectioncertificate20220627105732453.pdf
24/06/2022
SPC Documents
Annex SPC
47
PDF
/8/5/4/2/0/0800802458/docs/301182_6_supplprotectioncertificate20220627105732513.pdf
24/06/2022
SPC Documents
Annex SPC
2
PDF
/8/5/4/2/0/0800802458/docs/301182_7_supplprotectioncertificate20220627105732470.pdf
24/06/2022
SPC Documents
Marketing Authorization SPC
3
PDF
/8/5/4/2/0/0800802458/docs/301182_8_supplprotectioncertificate20220627105732430.pdf
24/06/2022
Application Form
First filed application form
3
PDF
/8/5/4/2/0/0800802458/docs/301182_9_applicationform20220627105732360.pdf